Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Novartis
University of Washington
Incyte Corporation
Incyte Corporation
Incyte Corporation
Prelude Therapeutics
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of California, Irvine
Disc Medicine, Inc
Massachusetts General Hospital
Incyte Corporation
Merck Sharp & Dohme LLC
Dartmouth-Hitchcock Medical Center
Fred Hutchinson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Incyte Corporation
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Center for International Blood and Marrow Transplant Research
University of Southern California
Washington University School of Medicine
Dana-Farber Cancer Institute
Brigham and Women's Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
University of Rochester
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Stanford University
Icahn School of Medicine at Mount Sinai
University Hospital, Angers
Geron Corporation
Icahn School of Medicine at Mount Sinai
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Incyte Corporation
Mayo Clinic
M.D. Anderson Cancer Center
Constellation Pharmaceuticals
Karyopharm Therapeutics Inc
Incyte Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ryvu Therapeutics SA